Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans

Hirohisa Takano, Naomi Osakabe, Chiaki Sanbongi, Rie Yanagisawa, Ken Ichiro Inoue, Akiko Yasuda, Midori Natsume, Seigo Baba, Ei Ichiro Ichiishi, Toshikazu Yoshikawa

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, suppresses allergic immunoglobulin responses and inflammation caused by polymorphonuclear leukocytes (PMNL) in mice. However, few placebo-controlled clinical trials have examined the efficacy and safety of polyphenolic phytochemicals for treatment of allergic inflammatory diseases in humans. The present study determined whether oral supplementation with rosmarinic acid is an effective intervention for patients with seasonal allergic rhinoconjunctivitis (SAR). In this 21-day, randomized, double-blind, age-matched, placebo-controlled parallel group study, patients with mild SAR were treated daily with extract of Perilla frutescens enriched for rosmarinic acid (200 mg [n = 10] or 50 mg [n = 9]) or placebo (n = 10). Patients recorded symptoms daily in a diary. Profiles of infiltrating cells and concentrations of eotaxin, IL-1β, IL-8, and histamine were measured in nasal lavage fluid. Serum IgE concentrations and routine blood tests were also examined. As compared with placebo supplementation, supplementation with extract of Perilla frutescens enriched for rosmarinic acid resulted in a significant increase in responder rates for itchy nose, watery eyes, itchy eyes, and total symptoms (P < 0.05). Active treatment significantly decreased the numbers of neutrophils and eosinophils in nasal lavage fluid (P < 0.05 vs. placebo). Patients reported no adverse events, and no significant abnormalities were detected in routine blood tests. In conclusion, extract of Perilla frutescens enriched for rosmarinic acid can be an effective intervention for mild SAR at least partly through inhibition of PMNL infiltration into the nostrils. Use of this alternative treatment for SAR might reduce treatment costs for allergic diseases.

Original languageEnglish
Pages (from-to)247-254
Number of pages8
JournalExperimental Biology and Medicine
Volume229
Issue number3
Publication statusPublished - 2004 Mar
Externally publishedYes

Fingerprint

Phytochemicals
Blood
Fluids
Interleukin-8
Interleukin-1
Infiltration
Immunoglobulin E
Histamine
Immunoglobulins
rosmarinic acid
Costs

Keywords

  • Alternative medicine
  • Extract of Perilla frutescens
  • Polymorphonuclear leukocytes
  • Randomized, double-blind, age-matched, placebo-controlled parallel group study
  • Rosmarinic acid
  • Seasonal allergic rhinoconjunctivitis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans. / Takano, Hirohisa; Osakabe, Naomi; Sanbongi, Chiaki; Yanagisawa, Rie; Inoue, Ken Ichiro; Yasuda, Akiko; Natsume, Midori; Baba, Seigo; Ichiishi, Ei Ichiro; Yoshikawa, Toshikazu.

In: Experimental Biology and Medicine, Vol. 229, No. 3, 03.2004, p. 247-254.

Research output: Contribution to journalArticle

Takano, H, Osakabe, N, Sanbongi, C, Yanagisawa, R, Inoue, KI, Yasuda, A, Natsume, M, Baba, S, Ichiishi, EI & Yoshikawa, T 2004, 'Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans', Experimental Biology and Medicine, vol. 229, no. 3, pp. 247-254.
Takano, Hirohisa ; Osakabe, Naomi ; Sanbongi, Chiaki ; Yanagisawa, Rie ; Inoue, Ken Ichiro ; Yasuda, Akiko ; Natsume, Midori ; Baba, Seigo ; Ichiishi, Ei Ichiro ; Yoshikawa, Toshikazu. / Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans. In: Experimental Biology and Medicine. 2004 ; Vol. 229, No. 3. pp. 247-254.
@article{9efc166947e84c9cbc0dee43ef0c6b0f,
title = "Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans",
abstract = "Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, suppresses allergic immunoglobulin responses and inflammation caused by polymorphonuclear leukocytes (PMNL) in mice. However, few placebo-controlled clinical trials have examined the efficacy and safety of polyphenolic phytochemicals for treatment of allergic inflammatory diseases in humans. The present study determined whether oral supplementation with rosmarinic acid is an effective intervention for patients with seasonal allergic rhinoconjunctivitis (SAR). In this 21-day, randomized, double-blind, age-matched, placebo-controlled parallel group study, patients with mild SAR were treated daily with extract of Perilla frutescens enriched for rosmarinic acid (200 mg [n = 10] or 50 mg [n = 9]) or placebo (n = 10). Patients recorded symptoms daily in a diary. Profiles of infiltrating cells and concentrations of eotaxin, IL-1β, IL-8, and histamine were measured in nasal lavage fluid. Serum IgE concentrations and routine blood tests were also examined. As compared with placebo supplementation, supplementation with extract of Perilla frutescens enriched for rosmarinic acid resulted in a significant increase in responder rates for itchy nose, watery eyes, itchy eyes, and total symptoms (P < 0.05). Active treatment significantly decreased the numbers of neutrophils and eosinophils in nasal lavage fluid (P < 0.05 vs. placebo). Patients reported no adverse events, and no significant abnormalities were detected in routine blood tests. In conclusion, extract of Perilla frutescens enriched for rosmarinic acid can be an effective intervention for mild SAR at least partly through inhibition of PMNL infiltration into the nostrils. Use of this alternative treatment for SAR might reduce treatment costs for allergic diseases.",
keywords = "Alternative medicine, Extract of Perilla frutescens, Polymorphonuclear leukocytes, Randomized, double-blind, age-matched, placebo-controlled parallel group study, Rosmarinic acid, Seasonal allergic rhinoconjunctivitis",
author = "Hirohisa Takano and Naomi Osakabe and Chiaki Sanbongi and Rie Yanagisawa and Inoue, {Ken Ichiro} and Akiko Yasuda and Midori Natsume and Seigo Baba and Ichiishi, {Ei Ichiro} and Toshikazu Yoshikawa",
year = "2004",
month = "3",
language = "English",
volume = "229",
pages = "247--254",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "0037-9727",
publisher = "Society for Experimental Biology and Medicine",
number = "3",

}

TY - JOUR

T1 - Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans

AU - Takano, Hirohisa

AU - Osakabe, Naomi

AU - Sanbongi, Chiaki

AU - Yanagisawa, Rie

AU - Inoue, Ken Ichiro

AU - Yasuda, Akiko

AU - Natsume, Midori

AU - Baba, Seigo

AU - Ichiishi, Ei Ichiro

AU - Yoshikawa, Toshikazu

PY - 2004/3

Y1 - 2004/3

N2 - Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, suppresses allergic immunoglobulin responses and inflammation caused by polymorphonuclear leukocytes (PMNL) in mice. However, few placebo-controlled clinical trials have examined the efficacy and safety of polyphenolic phytochemicals for treatment of allergic inflammatory diseases in humans. The present study determined whether oral supplementation with rosmarinic acid is an effective intervention for patients with seasonal allergic rhinoconjunctivitis (SAR). In this 21-day, randomized, double-blind, age-matched, placebo-controlled parallel group study, patients with mild SAR were treated daily with extract of Perilla frutescens enriched for rosmarinic acid (200 mg [n = 10] or 50 mg [n = 9]) or placebo (n = 10). Patients recorded symptoms daily in a diary. Profiles of infiltrating cells and concentrations of eotaxin, IL-1β, IL-8, and histamine were measured in nasal lavage fluid. Serum IgE concentrations and routine blood tests were also examined. As compared with placebo supplementation, supplementation with extract of Perilla frutescens enriched for rosmarinic acid resulted in a significant increase in responder rates for itchy nose, watery eyes, itchy eyes, and total symptoms (P < 0.05). Active treatment significantly decreased the numbers of neutrophils and eosinophils in nasal lavage fluid (P < 0.05 vs. placebo). Patients reported no adverse events, and no significant abnormalities were detected in routine blood tests. In conclusion, extract of Perilla frutescens enriched for rosmarinic acid can be an effective intervention for mild SAR at least partly through inhibition of PMNL infiltration into the nostrils. Use of this alternative treatment for SAR might reduce treatment costs for allergic diseases.

AB - Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, suppresses allergic immunoglobulin responses and inflammation caused by polymorphonuclear leukocytes (PMNL) in mice. However, few placebo-controlled clinical trials have examined the efficacy and safety of polyphenolic phytochemicals for treatment of allergic inflammatory diseases in humans. The present study determined whether oral supplementation with rosmarinic acid is an effective intervention for patients with seasonal allergic rhinoconjunctivitis (SAR). In this 21-day, randomized, double-blind, age-matched, placebo-controlled parallel group study, patients with mild SAR were treated daily with extract of Perilla frutescens enriched for rosmarinic acid (200 mg [n = 10] or 50 mg [n = 9]) or placebo (n = 10). Patients recorded symptoms daily in a diary. Profiles of infiltrating cells and concentrations of eotaxin, IL-1β, IL-8, and histamine were measured in nasal lavage fluid. Serum IgE concentrations and routine blood tests were also examined. As compared with placebo supplementation, supplementation with extract of Perilla frutescens enriched for rosmarinic acid resulted in a significant increase in responder rates for itchy nose, watery eyes, itchy eyes, and total symptoms (P < 0.05). Active treatment significantly decreased the numbers of neutrophils and eosinophils in nasal lavage fluid (P < 0.05 vs. placebo). Patients reported no adverse events, and no significant abnormalities were detected in routine blood tests. In conclusion, extract of Perilla frutescens enriched for rosmarinic acid can be an effective intervention for mild SAR at least partly through inhibition of PMNL infiltration into the nostrils. Use of this alternative treatment for SAR might reduce treatment costs for allergic diseases.

KW - Alternative medicine

KW - Extract of Perilla frutescens

KW - Polymorphonuclear leukocytes

KW - Randomized, double-blind, age-matched, placebo-controlled parallel group study

KW - Rosmarinic acid

KW - Seasonal allergic rhinoconjunctivitis

UR - http://www.scopus.com/inward/record.url?scp=10744221743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744221743&partnerID=8YFLogxK

M3 - Article

VL - 229

SP - 247

EP - 254

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 0037-9727

IS - 3

ER -